Gilead, J&J, Medivir hepatitis drugs show high cure rates taken together
This article was originally published in Scrip
Executive Summary
Gilead Sciences’ hepatitis C drug sofosbuvir combined with Johnson & Johnson and Medivir’s simeprevir creates a highly effective therapy for curing patients, including those who are hard to treat, new study data show.